Clinical Decision Making in Action: A Medical Student With Bipolar Disorder
neuroscienceCME Medical Simulation
Premiere Date: Friday, May 23, 2014This activity offers CE credit for:
- Physicians (CME)
- Nurses (CNE)
- Pharmacists (ACPE)
- Other
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Saturday, May 23, 2015
Note: Credit Is No Longer Available
 | Daniel J. Buysse, MD Professor of Psychiatry and Clinical and Translational Science Director, Neuroscience Clinical and Translational Research Center University of Pittsburgh School of Medicine Pittsburgh, PA |
Enter Exam Room #2 and find Madeline, a 27-year-old medical student with a personal and positive family history of bipolar disorder. She has been functioning well and adhering to her treatment regimen of medication and cognitive behavioral therapy. She shares her news of a match to an anesthesiology residency program and is mindful of the implications that the stressors and intensity of the training can present for her bipolar disorder. Your task is to help her navigate the potential challenges ahead.
The neuroscienceCME clinical simulation platform offers a safe learning environment where your choices determine your path and outcomes, and you can track your progress through the case. An expert faculty mentor will provide content-specific commentary on your choices and help guide you to the correct diagnosis and optimal treatment plan. Learning objectives and content on evidence-based, best practices for the correct diagnosis and treatment will be shared throughout the clinical simulation.
This educational activity centers on the CMEO Make-One-Change Statement. This statement is crafted from pertinent quality measures or clinical guidelines as a performance challenge to all participants.
Initiate and maintain a solid communication dynamic with patients with bipolar disorder so that they understand the role of sleep in bipolar disorder outcomes.
At the end of this CE activity, participants should be able to:
- Initiate and maintain a solid communication dynamic with patients with bipolar disorder so that they understand the role of sleep in bipolar disorder outcomes.
- Accurately and routinely administer validated questionnaires to improve detection of sleep disturbance in patients with bipolar disorder.
- Employ evidence-based and measure-based care strategies to optimize outcomes for patients with bipolar disorder.
Supported by an educational grant from Teva Pharmaceuticals.
Physicians, physician assistants, nurse practitioners, nurses, and pharmacists with an interest in sleep and mood disorders.
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.0 contact hour.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)
Universal Activity Number: 0376-0000-14-003-H01-P (recorded programs)
Activity Type: application-based
Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/TST823 (requires free account activation), and participants can print their certificate or statement of credit immediately (80% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.
Disclosure Declaration
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Buyssee has disclosed that he serves as a consultant to Esai Inc.; General Sleep Corporation; Merck & Co., Inc.; Philips Respironics; Purdue Pharma L.P. He has received financial support for educational lectures from Servier and Astellas Pharma Inc.
Tony Graham, MD (peer reviewer) has no disclosures to report.
Ruth Cody, BSN, RN-BC (peer reviewer) has no disclosures to report.
Catherine Friederich Murray, NASW (planning committee) has no disclosures to report.
Joy Bartnett Leffler, MLA, NASW, CSE (planning committee) has no disclosures to report.
Sandra Haas Binford, MAEd (planning committee) has no disclosures to report.
Sharon Tordoff, CCMEP (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: Nothing to disclose.
Unlabeled Use Disclosure
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
CME Outfitters, LLC, the faculty, and Teva Pharmaceuticals do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
PL-049-052014-15
